Litigation Details for AstraZeneca Pharmaceuticals LP v. Teva Pharmaceuticals USA Inc. (D. Del. 2014)
✉ Email this page to a colleague
AstraZeneca Pharmaceuticals LP v. Teva Pharmaceuticals USA Inc. (D. Del. 2014)
| Docket | ⤷ Try a Trial | Date Filed | 2014-12-11 |
| Court | District Court, D. Delaware | Date Terminated | 2016-06-27 |
| Cause | 35:271 Patent Infringement | Assigned To | Gregory Moneta Sleet |
| Jury Demand | None | Referred To | |
| Parties | ASTRAZENECA AB | ||
| Patents | 6,858,576; 6,872,700; 6,902,744; 6,956,026; 7,297,761; 7,521,423; 7,741,269 | ||
| Attorneys | Michael P. Kelly | ||
| Firms | Shaw Keller LLP, I.M. Pei Building | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in AstraZeneca Pharmaceuticals LP v. Teva Pharmaceuticals USA Inc.
The small molecule drugs covered by the patents cited in this case are ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , and ⤷ Try a Trial .
Details for AstraZeneca Pharmaceuticals LP v. Teva Pharmaceuticals USA Inc. (D. Del. 2014)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2014-12-11 | 1 | Complaint | expiration of U.S. Patent Nos. 6,858,576 (the “’576 patent”), 6,872,700 (the “’700 patent”), 6,956,026 (the…Paragraph IV Certification Concerning U.S. Patent Nos. 6,858,576, 6,872,700, 6,902,744, 6,956,026, 7,297,761…of the ’576 patent, the ’700 patent, the ’026 patent, the ’744 patent, and the ’423 patent (collectively…(the “’026 patent”), 7,297,761 (the “’761 patent”), 6,902,744 (the “’744 patent”), 7,521,423 (the “’423… This action is for patent infringement, brought pursuant to the patent laws of the United States | External link to document |
| 2015-02-08 | 16 | Answer to Counterclaim | United States Patent No. 6,858,576 19. Plaintiffs repeat and… United States Patent No. 6,858,576 39. Plaintiffs repeat and…744 patent and at times to the ’423 patent. To the extent paragraph 57 refers to the ’744 patent, Plaintiffs…744 patent and at times to the ’423 patent. To the extent paragraph 58 refers to the ’744 patent, Plaintiffs…the ’576, ’700, ’026, ’744 and ’423 patents and two other patents. Plaintiffs further admit that Teva | External link to document |
| 2014-12-11 | 4 | Patent/Trademark Report to Commissioner | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,858,576; 6,872,700; 6,956,026…2014 27 June 2016 1:14-cv-01478 830 Patent None District Court, D. Delaware | External link to document |
| 2015-06-08 | 41 | Notice of Service | Identification of Asserted Claims of U.S. Patent Nos. 7,297,761 & 7,741,269 filed by Amylin Pharmaceuticals…2014 27 June 2016 1:14-cv-01478 830 Patent None District Court, D. Delaware | External link to document |
| 2015-06-29 | 43 | SO ORDERED | serve its invalidity contentions as to U.S. Patent Nos. 6,858,576; 6,872,700; 6,956,026; 7,741,269…non- infringement contentions as to U.S. Patent Nos. 7,297,761 and 7,741,269 is extended to … to serve its infringement contentions for U.S. Patent Nos. 7,297,761 and 7,741,269 is extended…2014 27 June 2016 1:14-cv-01478 830 Patent None District Court, D. Delaware | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
